InvestorsHub Logo
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 51552

Monday, 02/06/2012 2:18:29 AM

Monday, February 06, 2012 2:18:29 AM

Post# of 97239
GNOM..$3.00 DD Post. Stock looks very undervalued here as it has a market cap of only 99m at a $3 closing price. Took a position at close on Friday. The company has $3.17 in cash per share. The book value per share is $3.10. The company has gotten beaten up from a disappointing Q3 in 2011. Genomic companies are solid right now. I think many biotech companies will eventually follow in the lead of Roche and look to gain a foothold in this space http://bloom.bg/wHbXRI . Hard to tell when but I like it when I see a company trading below cash in a hot industry. The next earning report is March 12th. The company is expecting to improve upon the last results that put their stock into a tailspin. This could be a solid trade in the short-term as a rebound of ($3.50-$4.00) could be on the way. The 52wk low is $2.21 & high is $18.55. The company has 24m in debt but also over 100m in cash. This looks to be a bottom here for now. Regardless, this looks like it could rebound here soon IMO.








Sheff's Station...All Aboard...Sign Up Here!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.